2-Oxoindoline-based hydroxamic acids: novel HDAC inhibitors with promising anticancer activity

Authors:

Abstract
Histone deacetylase (HDAC) inhibitors are important epigenetic anticancer agents that regulate gene expression, induce cell cycle arrest, and promote apoptosis.

This publication has 49 references indexed in Scilit: